Search Page

1

Cite

Share

Lactic acidosis induced by metformin: incidence, management and prevention.

Lalau JD. Lalau JD. Drug Saf. 2010 Sep 1;33(9):727-40. doi: 10.2165/11536790-000000000-00000. Drug Saf. 2010. PMID: 20701406 Review.

Cite

Share

2

Cite

Share

Therapeutic Concentrations of Metformin: A Systematic Review.

Kajbaf F, De Broe ME, Lalau JD. Kajbaf F, et al. Among authors: lalau jd. Clin Pharmacokinet. 2016 Apr;55(4):439-59. doi: 10.1007/s40262-015-0323-x. Clin Pharmacokinet. 2016. PMID: 26330026 Review.

Cite

Share

3

Cite

Share

[Management of eating disorders in schizophrenia].

Kouidrat Y, Amad A, Renard N, Corneille F, Lalau JD, Loas G. Kouidrat Y, et al. Among authors: lalau jd. Soins Psychiatr. 2016 May-Jun;(304):39-43. doi: 10.1016/j.spsy.2015.04.011. Soins Psychiatr. 2016. PMID: 27157198 Review. French.

Cite

Share

4

Cite

Share

The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis.

Kajbaf F, Lalau JD. Kajbaf F, et al. Among authors: lalau jd. BMC Pharmacol Toxicol. 2013 Apr 12;14:22. doi: 10.1186/2050-6511-14-22. BMC Pharmacol Toxicol. 2013. PMID: 23587368 Free PMC article.

Cite

Share

5

Cite

Share

Mortality rate in so-called "metformin-associated lactic acidosis": a review of the data since the 1960s.

Kajbaf F, Lalau JD. Kajbaf F, et al. Among authors: lalau jd. Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1123-7. doi: 10.1002/pds.3689. Epub 2014 Jul 31. Pharmacoepidemiol Drug Saf. 2014. PMID: 25079826 Review.

Cite

Share

6

Cite

Share

Erythrocyte metformin levels in patients with type 2 diabetes and varying severity of chronic kidney disease.

Briet C, Saraval-Gross M, Kajbaf F, Fournier A, Hary L, Lalau JD. Briet C, et al. Among authors: lalau jd. Clin Kidney J. 2012 Feb;5(1):65-67. doi: 10.1093/ndtplus/sfr134. Clin Kidney J. 2012. PMID: 24596656 Free PMC article. No abstract available.

Cite

Share

7

Cite

Share

Establishment of a database of metformin plasma concentrations and erythrocyte levels in normal and emergency situations.

Lalau JD, Lemaire-Hurtel AS, Lacroix C. Lalau JD, et al. Clin Drug Investig. 2011;31(6):435-8. doi: 10.2165/11588310-000000000-00000. Clin Drug Investig. 2011. PMID: 21401215

Cite

Share

8

Cite

Share

Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world.

Kajbaf F, Arnouts P, de Broe M, Lalau JD. Kajbaf F, et al. Among authors: lalau jd. Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1027-35. doi: 10.1002/pds.3501. Epub 2013 Aug 19. Pharmacoepidemiol Drug Saf. 2013. PMID: 23960029 Review.

Cite

Share

9

Cite

Share

Mortality and metformin use in patients with advanced chronic kidney disease.

Lalau JD, Kajbaf F, Arnouts P, de Broe M. Lalau JD, et al. Lancet Diabetes Endocrinol. 2015 Sep;3(9):680-1. doi: 10.1016/S2213-8587(15)00285-5. Lancet Diabetes Endocrinol. 2015. PMID: 26298570 No abstract available.

Cite

Share

10

Cite

Share

Metformin Poisoning: A Debate on Recommendations for Extracorporeal Treatment.

Lalau JD, Kajbaf F. Lalau JD, et al. Crit Care Med. 2015 Nov;43(11):e534. doi: 10.1097/CCM.0000000000001229. Crit Care Med. 2015. PMID: 26468726 No abstract available.

Cite

Share